Excitement around hydroxychloroquine for treating COVID-19 causes challenges for rheumatology
Brian Owens
Topics & Concepts
HydroxychloroquineCoronavirus disease 2019 (COVID-19)RheumatologyPandemicMedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakCoronavirusInternal medicineArthritisAntirheumatic AgentsIntensive care medicineDiseaseVirologyInfectious disease (medical specialty)OutbreakPeripheral Neuropathies and DisordersDrug-Induced Ocular ToxicityRheumatoid Arthritis Research and Therapies